CURE.ASX
ETFs S&P Biotech ETF
https://www.marketindex.com.au/asx/cure/financials

Annual Financial Summary

06/2020
06/2019
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Profitability
NPAT ($) 2,098,000 201,917 - - - - - - - -
NPAT Margin -- -- - - - - - - - -
Return on Equity (ROE) 18.90% 3.82% - - - - - - - -
Return on Assets (ROA) 17.03% 3.73% - - - - - - - -
Valuation
PE Ratio 5.25 25.75 - - - - - - - -
PE Relative to Market 25.4% 100.2% - - - - - - - -
Price to Book 0.99 0.98 - - - - - - - -
Price to Cash Flow 7.50 36.79 - - - - - - - -
Shares Outstanding (M) 0.18 0.10 - - - - - - - -
Market Cap ($M) $11.02 $5.20 - - - - - - - -
Enterprise Value ($M) $10.92 $5.20 - - - - - - - -
Performance
Total Shareholder Return 30.7% 0.0% - - - - - - - -
Relative to Market 37.9% 0.0% - - - - - - - -
Per Share
Earnings 1.00 302.88 - - - - - - - -
Cash Flow (2.00) (7.00) - - - - - - - -
Cash 0.53 0.00 - - - - - - - -
Net Tangible Assets 61.66 52.92 - - - - - - - -
Book Value 61.66 52.92 - - - - - - - -
Share Price $61.20 $52.00 - - - - - - - -
Liquidity
Quick Ratio 0.08 0.00 - - - - - - - -
Current Ratio 0.08 0.00 - - - - - - - -
Efficiency
Asset Turnover 0.00 0.00 - - - - - - - -
Inventory Turnover - - - - - - - - - -
Working Capital Turnover 0.00 0.00 - - - - - - - -
Dividends
DPS (c) 675.62 117.39 - - - - - - - -
Dividend yield 11.04% 2.26% - - - - - - - -
Franking - - - - - - - - - -
Gross DPS (c) 675.62 117.39 - - - - - - - -
Gross Dividend Yield 11.04% 2.26% - - - - - - - -
Payout Ratio 58% 58% - - - - - - - -
Membership required
Member Content
Source:
Morningstar Logo

Annual Financial Income Statement

06/2020
06/2019
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Revenue from Operations
Investment Income 1,276,000 125,743 - - - - - - - -
Other Income - - - - - - - - - -
Expenses (116,000) (8,830) - - - - - - - -
Profit / Loss before income tax 2,098,000 201,917 - - - - - - - -
Tax Expense - - - - - - - - - -
NPAT before Abnormals 2,098,000 201,917 - - - - - - - -
Abnormals - - - - - - - - - -
Abnormals Tax - - - - - - - - - -
Net Abnormals - - - - - - - - - -
Outside Equity - - - - - - - - - -
Preference Dividends - - - - - - - - - -
Reported NPAT after Abnormals 2,098,000 201,917 - - - - - - - -
EQUITY
Share End 180,000 100,000 - - - - - - - -
Share Weighted 180,000 100,000 - - - - - - - -
Ordinary Dividends (1,217,000) (117,388) - - - - - - - -
EPS Adjusted 11,655,600 2,019,200 - - - - - - - -
EPS after Abs 11,655,556 2,019,170 - - - - - - - -
Equity Profit / Loss - - - - - - - - - -
Membership required
Member Content
Source:
Morningstar Logo

Annual Financial Balance Sheet

06/2020
06/2019
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
CURRENT ASSETS
Cash and Cash Equivalents 0.1 - - - - - - - - -
Receivables - - - - - - - - - -
Investments - - - - - - - - - -
Other Current Assets - - - - - - - - - -
Total Current Assets 0.1 - - - - - - - - -
NON-CURRENT ASSETS
Investments 12.22 5.41 - - - - - - - -
Property - - - - - - - - - -
Other Non-Current Assets - - - - - - - - - -
Total Non-Current Assets 12.22 5.41 - - - - - - - -
TOTAL CURRENT LIABILITIES 12.32 5.41 - - - - - - - -
CURRENT LIABILITIES
Creditors 0.01 - - - - - - - - -
Provisions 1.22 0.12 - - - - - - - -
Other Liabilities - - - - - - - - - -
TOTAL CURRENT LIABILITIES 1.22 0.12 - - - - - - - -
NON-CURRENT LIABILITIES
Borrowings - - - - - - - - - -
Deferred Tax - - - - - - - - - -
Other Non-Current Liabilities - - - - - - - - - -
TOTAL NON-CURRENT LIABILITIES - - - - - - - - - -
TOTAL LIABILITIES 1.22 0.12 - - - - - - - -
NET ASSETS 13.54 5.53 - - - - - - - -
Total Equity Attr. to Holders 11.1 5.29 - - - - - - - -
Outside Equity - - - - - - - - - -
TOTAL EQUITY 11.1 5.29 - - - - - - - -
Membership required
Member Content
Source:
Morningstar Logo

Annual Financial Cash Flow

06/2020
06/2019
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
CASH FLOWS FROM OPERATING ACTIVITIES
Receipts 5.98 1.03 - - - - - - - -
Payments (10.62) (6.26) - - - - - - - -
Funds from Operations - - - - - - - - - -
Dividends Received 0.01 - - - - - - - - -
Interest Received - - - - - - - - - -
Interest Paid - - - - - - - - - -
Tax Paid - - - - - - - - - -
Other Operating Cash (0.08) - - - - - - - - -
NET CASH FROM OPERATING ACTIVITIES (4.7) (5.22) - - - - - - - -
CASH FLOWS FROM INVESTING ACTIVITIES
Receipts - - - - - - - - - -
Payments - - - - - - - - - -
PP&E - - - - - - - - - -
Proceeds PP&E - - - - - - - - - -
Purchase Subsidiary - - - - - - - - - -
Proceeds Subsidiary - - - - - - - - - -
Loans Granted - - - - - - - - - -
Loans Repaid - - - - - - - - - -
Other Investing Cash - - - - - - - - - -
NET CASH FROM INVESTING ACTIVITIES - - - - - - - - - -
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Issue 4.92 5.21 - - - - - - - -
Proceeds from Borrowings - - - - - - - - - -
Borrowings - - - - - - - - - -
Dividends Paid (0.11) - - - - - - - - -
Other Financing Cash - - - - - - - - - -
NET CASH FROM FINANCING ACTIVITIES 4.81 5.21 - - - - - - - -
NET CHANGE IN CASH 0.11 (0.02) - - - - - - - -
CASH AT START - - - - - - - - - -
Exchange Rate Adjustment (0.01) 0.01 - - - - - - - -
Other Cash Adjustment - - - - - - - - - -
CASH AT END 0.1 - - - - - - - - -
Membership required
Member Content
Source:
Morningstar Logo